0.37p+0.02 (+5.80%)12 Apr 2024, 17:15
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Oxford Cannabinoid Technologies Holdings PLC Market & Company News

11.04.2024 13:18OCTPOxford Cannabinoid teams with iNGENu to test OCT130401 pain treatmentAlliance
11.04.2024 11:26OCTPAppointment of Phase I Clinical Trial CRORNS
03.04.2024 08:00OCTPOCT Company Update with DoceoReach
26.03.2024 10:56OCTPOxford Cannabinoid Technologies video with DoceoReach
18.03.2024 07:00OCTPAppointment of Hybridan as AdviserRNS
29.02.2024 07:02OCTPDirectorate AppointmentRNS
29.02.2024 07:01OCTPDirectorate ChangesRNS
29.02.2024 07:00OCTPTotal Voting RightsRNS
28.02.2024 17:35OCTPTR-1: NOTIFICATION OF MAJOR HOLDINGSRNS
28.02.2024 17:34OCTPTR-1: NOTIFICATION OF MAJOR HOLDINGSRNS
28.02.2024 17:34OCTPTR-1: NOTIFICATION OF MAJOR HOLDINGSRNS
26.02.2024 13:07OCTPDirectors’ DealingsRNS
19.02.2024 13:52OCTPResult of General MeetingRNS
16.02.2024 14:36OCTPIN BRIEF: Oxford Cannabinoid completes capital reorganisationAlliance
16.02.2024 07:00OCTPCompletion of Capital ReorganisationRNS
15.02.2024 11:54OCTPIN BRIEF: Oxford Cannabinoid shares up on applying to admit new sharesAlliance
15.02.2024 07:00OCTPSubscriptionRNS
14.02.2024 19:55OCTPIN BRIEF: Oxford Cannabinoid applies for new shares to be listedAlliance
14.02.2024 12:53OCTPCapital ReorganisationRNS
12.02.2024 14:04RESI, OCTP, EISBUK shareholder meetings calendar - next 7 daysAlliance
02.02.2024 15:56OCTPIN BRIEF: Oxford Cannabinoid agrees GBP565,000 loan notes dealAlliance
30.01.2024 11:27OCTPOxford Cannabinoid Technologies down after GBP1.2 million fundraiseAlliance
30.01.2024 07:04OCTPFundraising and Proposed Capital ReorganisationRNS
30.01.2024 07:02OCTPR&D Tax CreditRNS
30.01.2024 07:00OCTPHalf-year ReportRNS
23.01.2024 14:32SYNT, STEM, SSPGUK earnings, trading statements calendar - next 7 daysAlliance
23.01.2024 07:00OCTPNotice of ResultsRNS
10.01.2024 11:46OCTPIN BRIEF: Oxford Cannabinoid stock goes high on Europe patent filingAlliance
10.01.2024 07:00OCTPPatent ApplicationsRNS
14.11.2023 07:00OCTPDirectorate AppointmentRNS
24.10.2023 07:00OCTPTR-1: Notification of major holdingsRNS
20.10.2023 09:37OCTPIN BRIEF: Kingsley Capital reduces stake in Oxford Cannabinoid Alliance
20.10.2023 07:01OCTPTR-1: Notification of major holdingsRNS
20.10.2023 07:00OCTPDirector DealingRNS
10.10.2023 11:34OCTPOxford Cannabinoid completes Phase 1 study for lead asset OCT461201Alliance
10.10.2023 07:00OCTPPhase I Clinical Trial ResultsRNS
29.09.2023 07:00OCTPResult of AGMRNS
25.09.2023 10:41OCTPOxford Cannabinoid issues final dose of lead pharmaceutical assetAlliance
25.09.2023 07:00OCTPFinal Dose AdministeredRNS
21.09.2023 15:50ZOO, TRU, REVBUK shareholder meetings calendar - next 7 daysAlliance
05.09.2023 16:18OCTPNotice of AGMRNS
31.08.2023 17:40OCTP, NAVF, IDHCEARNINGS SUMMARY: Gulf Keystone swings to loss; Gulf Marine optimisticAlliance
31.08.2023 09:53OCTP, PALM, ALFASMALL-CAP WINNERS & LOSERS: PPHE Hotels rises on swing to profitAlliance
31.08.2023 07:00OCTP2023 Final ResultsRNS
24.08.2023 15:47SOM, REVB, PBEEUK earnings, trading statements calendar - next 7 daysAlliance
22.08.2023 07:00OCTPNotice of ResultsRNS
27.07.2023 18:22OCTP, MILA, ADT1TRADING UPDATES: Pod Point cuts outlook; CVS Group buys in AustraliaAlliance
27.07.2023 07:00OCTPFirst Dose Administered & Pain Specialist AdviserRNS
17.07.2023 13:16OCTPDirector/PDMR Share PurchasesRNS
17.07.2023 10:30OCTPOxford Cannabinoid expands into oncology; discovers tumour treatment Alliance
17.07.2023 07:00OCTPExpansion into oncologyRNS
12.07.2023 07:00OCTPInvestor Presentation and Q&A – Programmes updateReach
15.06.2023 09:50OCTPOCTP update from DoceoReach
08.06.2023 12:36OCTPIN BRIEF: Oxford Cannabinoid appoints Nodenza's Tim Corn as new CMOAlliance
08.06.2023 07:00OCTPAppointment of Chief Medical OfficerRNS
17.05.2023 19:46OCTPIN BRIEF: Oxford Cannabinoid clinical trial application approvedAlliance
17.05.2023 07:00OCTPMHRA & REC 2 Approval for Phase 1 Clinical TrialRNS
12.04.2023 14:20OCTPIN BRIEF: Oxford Cannabinoid shares up as Sowemimo-Coker named CEOAlliance
12.04.2023 07:00OCTPDirectorate Change, Renewal of Licence & UpdateRNS
14.03.2023 14:05OCTPSecond Price Monitoring ExtnRNS
14.03.2023 14:00OCTPPrice Monitoring ExtensionRNS
13.03.2023 16:35OCTPPrice Monitoring ExtensionRNS
07.03.2023 11:05OCTPSecond Price Monitoring ExtnRNS
07.03.2023 11:00OCTPPrice Monitoring ExtensionRNS
06.03.2023 11:05OCTPSecond Price Monitoring ExtnRNS
06.03.2023 11:00OCTPPrice Monitoring ExtensionRNS
25.01.2023 12:09OCTPHolding in CompanyRNS
23.01.2023 14:17OCTPOxford Cannabinoid interim loss nearly doubles as research costs surgeAlliance
23.01.2023 07:00OCTPHalf-year ReportRNS
16.01.2023 15:38OCTPUK earnings, trading statements calendar - next 7 daysAlliance
16.01.2023 07:00OCTPAppointment of General Counsel & Notice of ResultsRNS
12.01.2023 21:20MVI, LND, PXCTRADING UPDATES: Arkle finds pegmatites; Apollon win license dealAlliance
12.01.2023 07:00OCTPUpdate on combined Clinical Trial ApplicationRNS
05.01.2023 12:27OCTPIN BRIEF: Oxford Cannabinoid submits trials application for agonistAlliance
05.01.2023 10:46OCTPSubmission of combined Clinical Trial ApplicationRNS
Showing 1 to 75 of 178